Open Access
Open access
Pathogens, volume 9, issue 3, pages 166

MmpS5-MmpL5 Transporters Provide Mycobacterium smegmatis Resistance to imidazo[1,2-b][1,2,4,5]tetrazines

Publication typeJournal Article
Publication date2020-02-28
Journal: Pathogens
Quartile SCImago
Q2
Quartile WOS
Q2
Impact factor3.7
ISSN20760817
Molecular Biology
Microbiology (medical)
Infectious Diseases
General Immunology and Microbiology
Immunology and Allergy
Abstract
The emergence and spread of drug-resistant Mycobacterium tuberculosis strains (including MDR, XDR, and TDR) force scientists worldwide to search for new anti-tuberculosis drugs. We have previously reported a number of imidazo[1,2-b][1,2,4,5]tetrazines–putative inhibitors of mycobacterial eukaryotic-type serine-threonine protein-kinases, active against M. tuberculosis. Whole genomic sequences of spontaneous drug-resistant M. smegmatis mutants revealed four genes possibly involved in imidazo[1,2-b][1,2,4,5]tetrazines resistance; however, the exact mechanism of resistance remain unknown. We used different approaches (construction of targeted mutants, overexpression of the wild-type (w.t.) and mutant genes, and gene-expression studies) to assess the role of the previously identified mutations. We show that mutations in MSMEG_1380 gene lead to overexpression of the mmpS5-mmpL5 operon in M. smegmatis, thus providing resistance to imidazo[1,2-b][1,2,4,5]tetrazines by increased efflux through the MmpS5-MmpL5 system, similarly to the mechanisms of resistance described for M. tuberculosis and M. abscessus. Mycobacterial MmpS5-MmpL5 transporters should be considered as an MDR-efflux system and they should be taken into account at early stages of anti-tuberculosis drug development.

Citations by journals

1
2
Pharmaceuticals
Pharmaceuticals, 2, 14.29%
Pharmaceuticals
2 publications, 14.29%
Biomedicines
Biomedicines, 1, 7.14%
Biomedicines
1 publication, 7.14%
Pathogens
Pathogens, 1, 7.14%
Pathogens
1 publication, 7.14%
Antibiotics
Antibiotics, 1, 7.14%
Antibiotics
1 publication, 7.14%
Frontiers in Microbiology
Frontiers in Microbiology, 1, 7.14%
Frontiers in Microbiology
1 publication, 7.14%
Nature Communications
Nature Communications, 1, 7.14%
Nature Communications
1 publication, 7.14%
Data in Brief
Data in Brief, 1, 7.14%
Data in Brief
1 publication, 7.14%
Chemical Reviews
Chemical Reviews, 1, 7.14%
Chemical Reviews
1 publication, 7.14%
Russian Journal of Genetics
Russian Journal of Genetics, 1, 7.14%
Russian Journal of Genetics
1 publication, 7.14%
FEMS Microbiology Reviews
FEMS Microbiology Reviews, 1, 7.14%
FEMS Microbiology Reviews
1 publication, 7.14%
Antimicrobial Agents and Chemotherapy
Antimicrobial Agents and Chemotherapy, 1, 7.14%
Antimicrobial Agents and Chemotherapy
1 publication, 7.14%
Microbial Pathogenesis
Microbial Pathogenesis, 1, 7.14%
Microbial Pathogenesis
1 publication, 7.14%
1
2

Citations by publishers

1
2
3
4
5
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 5, 35.71%
Multidisciplinary Digital Publishing Institute (MDPI)
5 publications, 35.71%
Elsevier
Elsevier, 2, 14.29%
Elsevier
2 publications, 14.29%
Frontiers Media S.A.
Frontiers Media S.A., 1, 7.14%
Frontiers Media S.A.
1 publication, 7.14%
Springer Nature
Springer Nature, 1, 7.14%
Springer Nature
1 publication, 7.14%
American Chemical Society (ACS)
American Chemical Society (ACS), 1, 7.14%
American Chemical Society (ACS)
1 publication, 7.14%
Pleiades Publishing
Pleiades Publishing, 1, 7.14%
Pleiades Publishing
1 publication, 7.14%
Oxford University Press
Oxford University Press, 1, 7.14%
Oxford University Press
1 publication, 7.14%
American Society for Microbiology
American Society for Microbiology, 1, 7.14%
American Society for Microbiology
1 publication, 7.14%
1
2
3
4
5
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Maslov D. A. et al. MmpS5-MmpL5 Transporters Provide Mycobacterium smegmatis Resistance to imidazo[1,2-b][1,2,4,5]tetrazines // Pathogens. 2020. Vol. 9. No. 3. p. 166.
GOST all authors (up to 50) Copy
Maslov D. A., Shur K. V., Vatlin A. A., Danilenko V. N. MmpS5-MmpL5 Transporters Provide Mycobacterium smegmatis Resistance to imidazo[1,2-b][1,2,4,5]tetrazines // Pathogens. 2020. Vol. 9. No. 3. p. 166.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.3390/pathogens9030166
UR - https://doi.org/10.3390%2Fpathogens9030166
TI - MmpS5-MmpL5 Transporters Provide Mycobacterium smegmatis Resistance to imidazo[1,2-b][1,2,4,5]tetrazines
T2 - Pathogens
AU - Maslov, Dmitry A
AU - Shur, Kirill V
AU - Vatlin, Aleksey A
AU - Danilenko, Valery N.
PY - 2020
DA - 2020/02/28 00:00:00
PB - Multidisciplinary Digital Publishing Institute (MDPI)
SP - 166
IS - 3
VL - 9
PMID - 32121069
SN - 2076-0817
ER -
BibTex |
Cite this
BibTex Copy
@article{2020_Maslov,
author = {Dmitry A Maslov and Kirill V Shur and Aleksey A Vatlin and Valery N. Danilenko},
title = {MmpS5-MmpL5 Transporters Provide Mycobacterium smegmatis Resistance to imidazo[1,2-b][1,2,4,5]tetrazines},
journal = {Pathogens},
year = {2020},
volume = {9},
publisher = {Multidisciplinary Digital Publishing Institute (MDPI)},
month = {feb},
url = {https://doi.org/10.3390%2Fpathogens9030166},
number = {3},
pages = {166},
doi = {10.3390/pathogens9030166}
}
MLA
Cite this
MLA Copy
Maslov, Dmitry A., et al. “MmpS5-MmpL5 Transporters Provide Mycobacterium smegmatis Resistance to imidazo[1,2-b][1,2,4,5]tetrazines.” Pathogens, vol. 9, no. 3, Feb. 2020, p. 166. https://doi.org/10.3390%2Fpathogens9030166.
Found error?